+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 1Day - 18Years
All Genders
ID06801223

Open-label Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Sulbactam-Durlobactam in Hospitalized Pediatric Patients Under 18 with Acinetobacter Baumannii-calcoaceticus Complex Infection

Led by Innoviva Specialty Therapeutics · Updated on 2026-10-06

48

Participants Needed

4

Research Sites

2 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to study the use of Sulbactam-Durlobactam SUL-DUR in pediatric patients from birth to under 18 years old who have suspected or confirmed infections caused by Acinetobacter baumannii-calcoaceticus complex ABC. The goal is to collect important data on how the drugs behave in the body pharmacokinetics and their safety to find the right dosing for children. The study is open-label and conducted in hospitalized children needing systemic antibiotic treatment for ABC infections. Participants will receive Sulbactam and Durlobactam at doses adjusted by age and weight, administered intravenously every 6 to 12 hours depending on their age group. Different dosing cohorts include children from birth with separate dosing for term and preterm infants up to less than 18 years old. The study is non-randomized and single-group, focusing on measuring drug concentrations on Days 1 and 3 and monitoring safety over 28 days. During the study, participants will have blood samples taken to assess drug levels and various health markers such as liver and kidney function, blood counts, and vital signs from baseline through Day 28. Adverse events and tolerability will be carefully recorded. The total participation lasts until 28 days after dosing to ensure thorough safety and pharmacokinetic evaluation of the treatment in this pediatric population.

CONDITIONS

Brief Title

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Research Team

I

ISTX Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here